https://idataresearch.com/wp-content/themes/lambda-child-theme/images/footer-logo.png
https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

Orthopedic Biomaterials

Showing 17–25 of 25 results

Orthopedic Cell Therapy Market Analysis | United States | 2019-2025 | MedCore

The scope of the orthopedic cell therapy market in this report covers platelet-rich plasma and concentrated bone marrow aspirate.
The platelet and bone marrow concentration market consists of centrifuge equipment that separates and concentrates platelets and cells based on their various densities. The majority of companies participating in this market provide the centrifuges on loan and sell only the disposable components, such as the spin buckets. Typically, one bucket is required per procedure.

more...

Orthopedic Growth Factor Market Analysis | United States | 2019-2025 | MedCore

Growth factors are a group of small, soluble proteins that bind onto cell surface receptors, triggering a series of signals that regulate the body’s ability to grow, renew and heal. Due to the regenerative properties of growth factors, they have been exploited for bone healing in orthopedic applications. Since September 1, 2015, there are two main growth factor products offered in the U.S. market: INFUSE® by Medtronic and AUGMENT® by Wright Medical. Stryker’s OP-1™ which had been sold to Olympus Biotech is no longer available as Olympus Biotech ceased sales May 31, 2014. Stryker’s OP-1™ is a different form of bone morphogenic proteins (BMPs) that belong to a larger family of proteins called transforming growth factors.

more...

Spinal Machined Bone Allograft Market Analysis | United States | 2019-2025 | MedCore

Spinal fusion is a surgical procedure designed to combine two or more vertebrae together, eventually forming a fused bone. It is primarily used for eliminating or significantly reducing the pain caused by abnormal movement of the vertebrae by immobilizing them. Supplemental bone tissue, either autograft or allograft, is used for promoting bone growth. A union of two vertebral bodies is referred to as a single-level fusion. Fusion is accomplished by using either an instrumented or non-instrumented surgical approach. Instrumented fusions incorporate fixation devices to secure and stabilize the fusion site, and interbody devices are used for filling the intervertebral disc space to enhance and promote fusion. Non-instrumented fusions utilize bone tissue to promote growth, but do not incorporate any implant devices into the procedures.

more...

Orthopedic Biomaterials Market Report Suite | Canada | 2016-2022 | MedSuite

Each of the three markets discussed in the report has a unique set of factors affecting its growth profile. In terms of the market drivers, for example, the bone graft market is seeing increasing adoption rate as newly trained surgeons are entering the workforce. The viscosupplementation market continues to bring improved products along with expanded indications. The bone stimulator market maintains a high clinical success rate and is therefore also increasing its adoption rate.

more...

Bone Growth Stimulators Market Analysis | Canada | 2016-2022 | MedCore

The very first bone stimulator device in Canada received Health Canada license in November 1999. As of 2015 there were a total of seven players in the long bone growth stimulator market, three of which also had either a separate device for spinal application or had their only device also indicated for spine. For the purpose of this report, estimated units were separated by indication and only long bone (i.e. fractures) related units were included. There is a brief discussion regarding the break-down between long bone and spinal units in the Electrical Stimulator Market section and under the competitive analysis section. For context, the long bone market is estimated to be more than seven times bigger than spine ($8.0 vs. $1.1 million, respectively) as of 2015. There is also a brief discussion on the estimated break-down between units sold and units rented under the Ultrasonic Stimulator Market section and under the competitive analysis section.

more...

Orthopedic Biomaterials Market Overview | Canada | 2016-2022 | MedView

Each of the three markets discussed in the report has a unique set of factors affecting its growth profile. In terms of the market drivers, for example, the bone graft market is seeing increasing adoption rate as newly trained surgeons are entering the workforce. The viscosupplementation market continues to bring improved products along with expanded indications. The bone stimulator market maintains a high clinical success rate and is therefore also increasing its adoption rate.

more...

Orthopedic Hyaluronic Acid Market Analysis | Canada | 2016-2022 | MedCore

One of the market limiters for the Canadian HA market is the reimbursement structure. None of the products are covered under standard healthcare plans and must be purchased directly or through extended healthcare coverage or private insurance. Thus, some patients opt out to receiving cortisone injections; these are reimbursed by standard healthcare and are a more affordable choice.
One of the factors that contributed positively to this market is ever expanding indication. The market originally started with treating osteoarthritis (OA) of the knee, since then some products expanded into hip, shoulder, a number of small joints, as well as assisting with post-surgery joint recovery.

more...

Spinal Bone Graft Substitutes Market Analysis | Canada | 2016-2022 | MedCore

Bone graft substitute products are utilized by dentists/periodontitis, neurosurgeons and orthopedic surgeons. Orthopedic indications represent the most major portion of the bone graft substitute market, with spinal fusions representing the most major category of surgery within that realm. For the purpose of this report, we do not assess the dental bone graft substitute market in any way. Instead, we focus on spinal indications for bone grafts and its size relative to the bone graft substitute market (excluding dental indications).

more...

Orthopedic Biomaterials, Bone Grafting and Hyaluronic Acid Viscosupplementation Market Report Suite | Asia-Pacific | 2011-2017 | MedSuite

The Asia-Pacific markets include Australia, China, Japan and South Korea. The orthopedic biomaterials market comprises autologous bone grafts, bone graft substitutes (segmented into allografts, demineralized bone matrices and synthetics), hyaluronic acid (HA) viscosupplementation and bone morphogenetic protein (BMP) growth factor therapy. The market is approaching maturity, but is expected to continue to grow as a result of the aging Asia-Pacific population. BMP growth factor therapy was the fastest-growing segment in 2010, increasing almost 7% over the previous year.

more...